ÍøºìºÚÁÏ

Skip to main content

Elias Sayour, MD, PhD

Pediatric Hematologist/Oncologist (Child Cancer Specialist)

Photo of Elias Sayour

Research at a glance

Top areas of exploration

  • Glioblastoma , 12 publications
  • Immunotherapy , 11 publications
  • Brain Neoplasms , 10 publications
  • T-Lymphocytes , 7 publications

Research activity

56 publications

2,148 citations

Why is this important?

Focus

Active clinical trials

PBTC-060

Patients will receive a vaccine called SurVaxM on this study. While vaccines are usually thought of as ways to prevent diseases, vaccines can also be used to treat cancer. SurVaxM is designed to tell the body's immune system to look for tumor cells…

Investigators
Elias Sayour, Jennifer F King
Status
Accepting Candidates
Ages
1 Year - 21 Years
Sexes
All

My publications

56 publications

2018

CD70, a novel target of CAR T-cell therapy for gliomas.

Neuro-oncology

•

2018

Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastoma.

The EMBO journal

•

2018

Personalized Tumor RNA Loaded Lipid-Nanoparticles Prime the Systemic and Intratumoral Milieu for Response to Cancer Immunotherapy

Nano Letters

•

2018

The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas.

Frontiers in molecular neuroscience

•

2017

CD4+ and Perivascular Foxp3+ T Cells in Glioma Correlate with Angiogenesis and Tumor Progression.

Frontiers in immunology

•